Companies: 10,644     total market cap: NZ$237.327 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Bristol-Myers Squibb
BMY
#167
Rank
NZ$210.17 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
NZ$103.20
Share price
0.57%
Change (1 day)
5.03%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Bristol-Myers Squibb (BMY) - Total assets

Total assets on the balance sheet as of December 2025 : NZ$150.84 Billion

According to Bristol-Myers Squibb's latest financial reports the company's total assets are NZ$150.84 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Bristol-Myers Squibb - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31NZ$155.46 B-5.32%
2024-12-31NZ$164.19 B9.12%
2023-12-31NZ$150.47 B-1.33%
2022-12-31NZ$152.49 B-4.71%
2021-12-31NZ$160.04 B-2.54%
2020-12-31NZ$164.20 B-14.89%
2019-12-31NZ$192.94 B269.92%
2018-12-31NZ$52.15 B10.41%
2017-12-31NZ$47.24 B-2.92%
2016-12-31NZ$48.66 B4.9%
2015-12-31NZ$46.38 B7.69%
2014-12-31NZ$43.07 B-8.28%
2013-12-31NZ$46.96 B7.62%
2012-12-31NZ$43.63 B3.29%
2011-12-31NZ$42.24 B4.88%
2010-12-31NZ$40.28 B-5.65%
2009-12-31NZ$42.69 B-15.98%
2008-12-31NZ$50.81 B48.71%
2007-12-31NZ$34.16 B-5.88%
2006-12-31NZ$36.30 B-11.82%
2005-12-31NZ$41.16 B-3.48%
2004-12-31NZ$42.65 B1.01%
2003-12-31NZ$42.22 B-11.69%
2002-12-31NZ$47.81 B-28.61%
2001-12-31NZ$66.97 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
NZ$333.75 B 121.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$185.88 B 23.22%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$349.70 B 131.83%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$224.33 B 48.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$188.44 B 24.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$151.02 B 0.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$255.20 B 69.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$49.32 B-67.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$217.04 B 43.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$191.11 B 26.70%๐Ÿ‡ฌ๐Ÿ‡ง UK

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com